JP2018504457A5 - - Google Patents

Download PDF

Info

Publication number
JP2018504457A5
JP2018504457A5 JP2017557279A JP2017557279A JP2018504457A5 JP 2018504457 A5 JP2018504457 A5 JP 2018504457A5 JP 2017557279 A JP2017557279 A JP 2017557279A JP 2017557279 A JP2017557279 A JP 2017557279A JP 2018504457 A5 JP2018504457 A5 JP 2018504457A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
acid
composition according
lactobacillus
administered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017557279A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018504457A (ja
JP6783247B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/014292 external-priority patent/WO2016118730A1/en
Publication of JP2018504457A publication Critical patent/JP2018504457A/ja
Publication of JP2018504457A5 publication Critical patent/JP2018504457A5/ja
Application granted granted Critical
Publication of JP6783247B2 publication Critical patent/JP6783247B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017557279A 2015-01-23 2016-01-21 ガン予防における短鎖脂肪酸の使用 Active JP6783247B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562106778P 2015-01-23 2015-01-23
US62/106,778 2015-01-23
PCT/US2016/014292 WO2016118730A1 (en) 2015-01-23 2016-01-21 Use of short chain fatty acids in cancer prevention

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020176442A Division JP2021020929A (ja) 2015-01-23 2020-10-21 ガン予防における短鎖脂肪酸の使用

Publications (3)

Publication Number Publication Date
JP2018504457A JP2018504457A (ja) 2018-02-15
JP2018504457A5 true JP2018504457A5 (cg-RX-API-DMAC10.html) 2019-02-28
JP6783247B2 JP6783247B2 (ja) 2020-11-11

Family

ID=56417737

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2017557279A Active JP6783247B2 (ja) 2015-01-23 2016-01-21 ガン予防における短鎖脂肪酸の使用
JP2020176442A Pending JP2021020929A (ja) 2015-01-23 2020-10-21 ガン予防における短鎖脂肪酸の使用
JP2022196339A Pending JP2023027219A (ja) 2015-01-23 2022-12-08 ガン予防における短鎖脂肪酸の使用
JP2024220908A Pending JP2025038120A (ja) 2015-01-23 2024-12-17 ガン予防における短鎖脂肪酸の使用

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2020176442A Pending JP2021020929A (ja) 2015-01-23 2020-10-21 ガン予防における短鎖脂肪酸の使用
JP2022196339A Pending JP2023027219A (ja) 2015-01-23 2022-12-08 ガン予防における短鎖脂肪酸の使用
JP2024220908A Pending JP2025038120A (ja) 2015-01-23 2024-12-17 ガン予防における短鎖脂肪酸の使用

Country Status (12)

Country Link
US (6) US10231941B2 (cg-RX-API-DMAC10.html)
EP (2) EP4748449A3 (cg-RX-API-DMAC10.html)
JP (4) JP6783247B2 (cg-RX-API-DMAC10.html)
KR (1) KR102735818B1 (cg-RX-API-DMAC10.html)
CN (2) CN107405321A (cg-RX-API-DMAC10.html)
AU (3) AU2016209244A1 (cg-RX-API-DMAC10.html)
IL (1) IL253581A0 (cg-RX-API-DMAC10.html)
MX (1) MX387817B (cg-RX-API-DMAC10.html)
RU (1) RU2017127597A (cg-RX-API-DMAC10.html)
SG (2) SG10201907660YA (cg-RX-API-DMAC10.html)
WO (1) WO2016118730A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA201704977B (cg-RX-API-DMAC10.html)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201112091D0 (en) 2011-07-14 2011-08-31 Gt Biolog Ltd Bacterial strains isolated from pigs
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
EP4529950A3 (en) 2014-10-31 2025-08-20 Pendulum Therapeutics, Inc. Methods and compositions relating to microbial treatment
DK3193901T3 (en) 2014-12-23 2018-05-28 4D Pharma Res Ltd PIRIN POLYPEPTIDE AND IMMUNMODULATION
PE20171138A1 (es) 2014-12-23 2017-08-09 4D Pharma Res Ltd Modulacion inmunitaria
PE20180243A1 (es) 2015-06-15 2018-01-31 4D Pharma Res Ltd Composiciones que comprenden cepas bacterianas
MA41060B1 (fr) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
MA41010B1 (fr) 2015-06-15 2020-01-31 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
EP3662917A1 (en) 2015-06-15 2020-06-10 4D Pharma Research Limited Compositions comprising bacterial strains
LT3360559T (lt) 2015-06-15 2019-12-27 4D Pharma Research Limited Kompozicijos, apimančios bakterijų kamienus
GB201520497D0 (en) 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
MA41013A (fr) 2015-11-20 2017-08-30 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
GB201520631D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520638D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
MX373290B (es) 2016-03-04 2020-06-18 4D Pharma Plc Composiciones que comprenden cepas bacterianas.
GB201612191D0 (en) 2016-07-13 2016-08-24 4D Pharma Plc Compositions comprising bacterial strains
TWI802545B (zh) 2016-07-13 2023-05-21 英商４Ｄ製藥有限公司 包含細菌菌株之組合物
WO2018089861A1 (en) * 2016-11-11 2018-05-17 The Regents Of The University Of California Methods and compositions for the treatment of cancer and metabolic diseases
GB201621123D0 (en) 2016-12-12 2017-01-25 4D Pharma Plc Compositions comprising bacterial strains
CN110475551A (zh) 2017-01-27 2019-11-19 英联邦高等教育系统天普大学 使用短链脂肪酸治疗和预防疾病和障碍
WO2018195067A1 (en) 2017-04-17 2018-10-25 The University Of Chicago Polymer materials for delivery of short-chain fatty acids to the intestine for applications in human health and treatment of disease
US20220304967A1 (en) * 2017-04-24 2022-09-29 Allerpops Oral microbiota promoting composition cross-reference to related applications
MA48940A (fr) 2017-05-22 2020-04-08 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
MA41708A (fr) 2017-05-24 2020-04-08 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
PL3638271T3 (pl) 2017-06-14 2021-03-22 4D Pharma Research Limited Kompozycje zawierające szczepy bakteryjne
JP2020523326A (ja) 2017-06-14 2020-08-06 フォーディー ファーマ リサーチ リミテッド４Ｄ Ｐｈａｒｍａ Ｒｅｓｅａｒｃｈ Ｌｉｍｉｔｅｄ 細菌株を含む組成物
TWI767013B (zh) 2017-06-14 2022-06-11 英商4D製藥研究有限公司 包含細菌品系之組成物
KR102563191B1 (ko) 2017-07-05 2023-08-02 에벨로 바이오사이언시즈, 인크. 비피도박테리움 애니멀리스 ssp. 락티스를 이용한 암 치료 조성물 및 방법
EP3661371A1 (en) * 2017-08-04 2020-06-10 Société des Produits Nestlé S.A. Probiotic bacteria preconditioned in a gos-containing medium and use thereof
WO2019046646A1 (en) 2017-08-30 2019-03-07 Whole Biome Inc. METHODS AND COMPOSITIONS FOR THE TREATMENT OF MICROBIOMA ASSOCIATED DISORDERS
CN110090230B (zh) * 2018-01-30 2022-07-12 青岛东海药业有限公司 凝结芽孢杆菌在制备预防或治疗胆管癌制剂中的应用
LT3743086T (lt) * 2018-05-11 2022-06-10 4D Pharma Research Limited Kompozicijos, apimančios bakterinius kamienus
SG11202011817WA (en) * 2018-06-01 2020-12-30 Evolve Biosystems Inc Compositions and methods to promote host defense and stimulate, expand, and/or reset t cell repertoires
CN113164526A (zh) 2018-07-19 2021-07-23 潘德勒姆治疗公司 用于微生物植入的方法和组合物
AU2020355194B2 (en) * 2019-09-25 2026-06-18 Julius-Maximilians-Universität Würzburg Short-chain fatty acid pentanoate as enhancer for cellular therapy and anti-tumor therapy
KR102510198B1 (ko) * 2019-11-14 2023-03-15 가톨릭대학교 산학협력단 락토바실러스 속 균주 및 SCFA(Short fatty chain acid)를 포함하는 면역 질환의 예방 및 치료용 조성물
TWI734341B (zh) * 2020-01-14 2021-07-21 景岳生物科技股份有限公司 一種副乾酪乳桿菌ｇｍｎｌ-３４６用於抗口腔癌之用途
EP4134089A1 (en) * 2020-03-05 2023-02-15 Liscure Biosciences Co., Ltd. Pharmaceutical composition comprising genus leuconostoc strain as active ingredient for prevention or treatment of cancer
WO2022031787A1 (en) * 2020-08-04 2022-02-10 Temple University-Of The Commonwealth System Of Higher Education Methods and compositions for treating cytokine release syndrome
US11938152B2 (en) 2020-08-06 2024-03-26 Kedar N Prasad High-dose antioxidants in cancer treatment
US20240009155A1 (en) * 2020-11-12 2024-01-11 Temple University-Of The Commonwealth System Of Higher Education Use of short chain fatty acids in cancer prevention
WO2022177409A1 (ko) * 2021-02-22 2022-08-25 주식회사 리스큐어바이오사이언시스 류코노스톡 메센테로이데스 균주 유래 나노소포체를 유효성분으로 포함하는 암의 예방 또는 치료용 약학 조성물
KR102942263B1 (ko) * 2021-11-05 2026-03-23 건국대학교 글로컬산학협력단 하이칸톤을 포함하는 우울장애 또는 신경염증질환의 예방 또는 치료용 조성물
CA3249056A1 (en) * 2022-01-19 2023-07-27 Ian Hodgdon SHORT CHAIN FATTY ACIDS FOR CANCER TREATMENT
CN117925434B (zh) * 2022-10-26 2025-02-14 慕恩（广州）生物科技有限公司 粪肠球菌mnh 22871及其应用
CN116212027A (zh) * 2023-02-28 2023-06-06 西湖大学 一种调控Treg细胞内铁水平的试剂的用途
AU2024405251A1 (en) 2023-12-22 2026-07-09 Temple University-Of The Commonwealth System Of Higher Education Short chain fatty acid compounds and uses thereof
WO2025176152A1 (en) * 2024-02-19 2025-08-28 The University Of Hong Kong Probiotics mixtures and methods of use thereof for treating cancers
CN119424400B (zh) * 2024-10-21 2026-03-03 江南大学 缓解衰老的肠道菌群支链氨基酸代谢产物异丁酸和异戊酸及其应用
CN119258047A (zh) * 2024-11-26 2025-01-07 哈尔滨医科大学 琥珀酸在制备防治肝癌药物中的新用途

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4735967A (en) 1985-05-28 1988-04-05 Neesby Torben E Method for desensitizing the gastrointestinal tract from food allergies
AU645070B2 (en) 1990-04-10 1994-01-06 Nb International Technologies Use of short chain fatty acid containing lipids to maintain gastrointestinal integrity and function in patients DO NOT SEAL - SEE LETTER DATED 22.03.94
PH31403A (en) 1991-03-01 1998-10-29 Warner Lambert Co Therapeutic compositions to protect and recuscitate mammalian cells and methods for preparing same.
WO1995011699A1 (en) 1993-10-29 1995-05-04 The Trustees Of Boston University Physiologically stable compositions of butyric acid, and butyric acid salts and derivatives as anti-neoplastic agents
JP2000072667A (ja) 1998-08-25 2000-03-07 Kurasuraa:Kk 大腸炎治療用経口投与剤
US6201077B1 (en) 1998-12-01 2001-03-13 Phillips Petroleum Company Process that produces polymers
EP1034788A1 (en) 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Lactic acid bacteria strains capable of preventing diarrhea
JP4360915B2 (ja) 2002-01-07 2009-11-11 ユーロスクリーン・ソシエテ・アノニム Ｇタンパク質共役受容体ｇｐｒ４３のリガンドおよびその使用
MXPA04008577A (es) 2002-03-04 2005-07-13 Aton Pharma Inc Metodos para inducir diferenciacion terminal.
JP2005530734A (ja) 2002-04-15 2005-10-13 スローン − ケッタリング インスティチュート フォー キャンサー リサーチ 癌の処置のための併用療法
US8846039B2 (en) 2002-04-26 2014-09-30 Asan Laboratories Company (Cayman), Limited Method for ameliorating pruritus
CN1681505A (zh) 2002-09-13 2005-10-12 弗吉尼亚州立大学 用于治疗白血病的а ) N－{ 5－[ 4－( 4－甲基－哌嗪－1－基－甲基)－苯甲酰氨基]－2－甲基苯基}－4－( 3－吡啶基 ) －2－嘧啶－胺和b )组蛋白脱乙酰基酶抑制剂的组合
US20050023179A1 (en) 2003-07-31 2005-02-03 Albritton Charles Wade Fragile-product cage for vacuum packaging appliances
CN102349927A (zh) 2003-08-29 2012-02-15 Hdac默克研究有限责任公司 联合治疗癌症的方法
WO2007016953A1 (en) 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing alcohol induced liver cancer risk
EP2389930A1 (en) * 2006-03-31 2011-11-30 Erasmus University Medical Center Rotterdam Novel composition for tumor growth control
WO2008054293A1 (en) * 2006-11-03 2008-05-08 Salutary Care Limited Composition, its use for treating systemic diseases a conditions, and product containing said composition
US20080153908A1 (en) 2006-12-20 2008-06-26 Jani Dharmendra M Method of Treating Mucin Deficiency with an Active Pharmaceutical and Related Composition
US9078864B2 (en) 2008-01-08 2015-07-14 Akthelia Pharmaceuticals Agonists for antimicrobial peptide systems
CN101214234B (zh) 2008-01-10 2010-09-08 中国人民解放军第二军医大学 α-羟基酸在制备癌瘤体内注射治疗药物中的应用
EP2398444A4 (en) 2009-02-18 2015-06-17 Sea Qiq As MIXTURE FROM INORGANIC COMPOUNDS, PREPARATIONS WITH THE MIXTURE AND USE OF THE MIXTURE
EP3181134B1 (en) 2009-06-19 2019-10-30 DuPont Nutrition Biosciences ApS Bifidobacteria for treating diabetes and related conditions
US8962686B2 (en) 2010-04-28 2015-02-24 The Chinese University Of Hong Kong Method and medication for prevention and treatment of ocular hypertension and glaucoma
EP2389932A1 (en) 2010-05-28 2011-11-30 Lunamed AG Compositions for use in genetic disorders comprising 4-phenyl-butyric acid and its salts
US20130115280A1 (en) 2010-07-29 2013-05-09 Cosmo Technologies Ltd Pharmaceutical and/or dietary compositions based on sort chain fatty acids
SG183544A1 (en) 2010-11-29 2012-10-30 Univ Putra Malaysia Tumour cytotoxic agent and methods thereof
CN111518866A (zh) * 2011-03-01 2020-08-11 群体创新有限责任公司 用于治疗与致病生物膜相关之病症的材料和方法
WO2012131069A1 (en) 2011-03-31 2012-10-04 Proponent Biotech Gmbh Short chain fatty acids and their derivatives for use in treatment immunogenic disorders
WO2012145684A1 (en) * 2011-04-22 2012-10-26 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Transient hypoxia inducers and their use
SG10202013014RA (en) * 2012-01-16 2021-02-25 Mckenna Elizabeth Compositions and Methods for the Treatment of Hepatic Diseases and Disorders
GB201215289D0 (en) 2012-08-28 2012-10-10 Medical Res Council Nanoparticle formulation
TWI463986B (zh) 2012-08-29 2014-12-11 Univ China Medical 胚芽乳酸桿菌ｃｍｕ９９５菌株之新用途
TWI472324B (zh) * 2013-05-14 2015-02-11 應用二甲雙胍與丁酸鈉於ｋｒａｓ基因突變癌症治療之用途、醫藥組合物與醫藥套組
US9764019B2 (en) 2013-07-09 2017-09-19 Vedanta Biosciences, Inc. Compositions containing combinations of bioactive molecules derived from microbiota for treatment of disease
EP3033091B1 (en) * 2013-08-16 2022-09-07 Versitech Limited Probiotic composition and use thereof in the prevention and treatment of hepatocellular carcinoma

Similar Documents

Publication Publication Date Title
RU2017127597A (ru) Применение короткоцепочечных жирных кислот для профилактики рака
AU2018333114B2 (en) New use for treatment of Clostridium difficile infections
RU2013126616A (ru) Замороженные кондитерские изделия, содержащие пробиотические микроорганизмы
Saxelin et al. Probiotic and other functional microbes: from markets to mechanisms
JP2016524900A5 (cg-RX-API-DMAC10.html)
RU2017132156A (ru) Способ индуцирования пероральной толерантности путем введения пептидов, полученных из бета-лактоглобулина, в сочетании с пробиотиком
RU2007106038A (ru) Композиция на основе пробиотических бактерий и ее применение в профилактике и/или лечении респираторных патологий и/или инфекций и в улучшении функции кишечника
JP2013507394A5 (cg-RX-API-DMAC10.html)
RU2011150216A (ru) Детские питательные смеси, содержащие пробиотические микроорганизмы
RU2011150201A (ru) Кратковременная высокотемпературная обработка для микробных препаратов с противовоспалительными свойствами
JP2017513906A5 (cg-RX-API-DMAC10.html)
EA200701992A1 (ru) Смесь по меньшей мере из 6 видов молочнокислых бактерий и/или бифидобактерий в производстве закваски
JP2008520640A5 (cg-RX-API-DMAC10.html)
WO2003080813A3 (en) Lactobacillus strains
JP2016529309A5 (cg-RX-API-DMAC10.html)
RU2013125765A (ru) Корма для домашних животных, содержащие пробиотические микроорганизмы
EP2432484A1 (en) Use of collinsella aerofaciens for reducing bloating
RU2013126609A (ru) Экструдированные нереплицирующиеся пробиотические микроорганизмы и их польза для здоровья
WO2007085970A3 (en) Use of probiotic microorganisms for the treatment and prevention of obesity and related disorders
MY207753A (en) Composition for maintenance and/or improvement of memory/learning ability, and food, medicine and feed each containing said composition
HRP20160945T1 (hr) Metoda za indukciju tolerancije na alergen
JP2008500294A5 (cg-RX-API-DMAC10.html)
RU2019116519A (ru) Композиция для направленной доставки биологически активного компонента в толстую кишку и ее применение
Swathi Probiotics-A human friendly bacteria
JP2024545441A5 (cg-RX-API-DMAC10.html)